Relationships among Inflammatory Biomarkers and Objectively Assessed Physical Activity and Sleep during and after Chemotherapy for Gynecologic Malignancies

Little is known regarding associations between inflammatory biomarkers and objectively measured physical activity and sleep during and after chemotherapy for gynecologic cancer; thus, we conducted a longitudinal study to address this gap. Women with gynecologic cancer (patients) and non-cancer contr...

Full description

Bibliographic Details
Main Authors: Danielle B. Tometich, Aasha I. Hoogland, Brent J. Small, Michelle C. Janelsins, Crystal Bryant, Yvelise Rodriguez, Brian D. Gonzalez, Xiaoyin Li, Hailey W. Bulls, Brian W. James, Bianca Arboleda, Claudia Colon-Echevarria, Mary K. Townsend, Shelley S. Tworoger, Paulo Rodriguez, Laura B. Oswald, Julienne E. Bower, Sachin M. Apte, Robert M. Wenham, Hye Sook Chon, Mian M. Shahzad, Heather S. L. Jim
Format: Article
Language:English
Published: MDPI AG 2023-07-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/15/15/3882
_version_ 1797586971034386432
author Danielle B. Tometich
Aasha I. Hoogland
Brent J. Small
Michelle C. Janelsins
Crystal Bryant
Yvelise Rodriguez
Brian D. Gonzalez
Xiaoyin Li
Hailey W. Bulls
Brian W. James
Bianca Arboleda
Claudia Colon-Echevarria
Mary K. Townsend
Shelley S. Tworoger
Paulo Rodriguez
Laura B. Oswald
Julienne E. Bower
Sachin M. Apte
Robert M. Wenham
Hye Sook Chon
Mian M. Shahzad
Heather S. L. Jim
author_facet Danielle B. Tometich
Aasha I. Hoogland
Brent J. Small
Michelle C. Janelsins
Crystal Bryant
Yvelise Rodriguez
Brian D. Gonzalez
Xiaoyin Li
Hailey W. Bulls
Brian W. James
Bianca Arboleda
Claudia Colon-Echevarria
Mary K. Townsend
Shelley S. Tworoger
Paulo Rodriguez
Laura B. Oswald
Julienne E. Bower
Sachin M. Apte
Robert M. Wenham
Hye Sook Chon
Mian M. Shahzad
Heather S. L. Jim
author_sort Danielle B. Tometich
collection DOAJ
description Little is known regarding associations between inflammatory biomarkers and objectively measured physical activity and sleep during and after chemotherapy for gynecologic cancer; thus, we conducted a longitudinal study to address this gap. Women with gynecologic cancer (patients) and non-cancer controls (controls) completed assessments before chemotherapy cycles 1, 3, and 6 (controls assessed contemporaneously), as well as at 6- and 12-month follow-ups. Physical activity and sleep were measured using wrist-worn actigraphs and sleep diaries, and blood was drawn to quantify circulating levels of inflammatory markers. Linear and quadratic random-effects mixed models and random-effects fluctuation mixed models were used to examine physical activity and sleep over time, as well as the associations with inflammatory biomarkers. On average, patients (<i>n</i> = 97) and controls (<i>n</i> = 104) were 62 and 58 years old, respectively. Compared to controls, patients were less active, more sedentary, had more time awake after sleep onset, and had lower sleep efficiency (<i>p</i>-values < 0.05). Across groups, higher levels of TNF-α were associated with more sedentary time and less efficient sleep (<i>p</i>-values ≤ 0.05). Higher levels of IL-1β, TNF-α, and IL-6 were associated with lower levels of light physical activity (<i>p</i>-values < 0.05). Associations between inflammatory biomarkers, physical activity, and sleep did not differ between patients and controls. Given these results, we speculate that inflammation may contribute to less physical activity and more sleep problems that persist even 12 months after completing chemotherapy.
first_indexed 2024-03-11T00:30:44Z
format Article
id doaj.art-c359b1ac05e446ea9ed011ad179d243c
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-11T00:30:44Z
publishDate 2023-07-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-c359b1ac05e446ea9ed011ad179d243c2023-11-18T22:42:41ZengMDPI AGCancers2072-66942023-07-011515388210.3390/cancers15153882Relationships among Inflammatory Biomarkers and Objectively Assessed Physical Activity and Sleep during and after Chemotherapy for Gynecologic MalignanciesDanielle B. Tometich0Aasha I. Hoogland1Brent J. Small2Michelle C. Janelsins3Crystal Bryant4Yvelise Rodriguez5Brian D. Gonzalez6Xiaoyin Li7Hailey W. Bulls8Brian W. James9Bianca Arboleda10Claudia Colon-Echevarria11Mary K. Townsend12Shelley S. Tworoger13Paulo Rodriguez14Laura B. Oswald15Julienne E. Bower16Sachin M. Apte17Robert M. Wenham18Hye Sook Chon19Mian M. Shahzad20Heather S. L. Jim21Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL 33612, USADepartment of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL 33612, USASchool of Aging Studies, University of South Florida, Tampa, FL 33620, USADepartment of Surgery and Neuroscience, University of Rochester Medical Center, Rochester, NY 14642, USADepartment of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL 33612, USADepartment of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL 33612, USADepartment of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL 33612, USADepartment of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL 33612, USASection of Palliative Care and Medical Ethics, Division of General Internal Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, PA 15260, USAMorsani College of Medicine, University of South Florida, Tampa, FL 33620, USAMorsani College of Medicine, University of South Florida, Tampa, FL 33620, USADepartment of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL 33612, USADepartment of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL 33612, USADepartment of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL 33612, USADepartment of Immunology, Moffitt Cancer Center, Tampa, FL 33612, USADepartment of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL 33612, USADepartment of Psychology, University of California Los Angeles, Los Angeles, CA 90095, USAHuntsman Cancer Institute, Department of Obstetrics and Gynecology, University of Utah, Salt Lake City, UT 84112, USADepartment of Gynecologic Oncology, Moffitt Cancer Center, Tampa, FL 33612, USADepartment of Gynecologic Oncology, Moffitt Cancer Center, Tampa, FL 33612, USADepartment of Gynecologic Oncology, Moffitt Cancer Center, Tampa, FL 33612, USADepartment of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL 33612, USALittle is known regarding associations between inflammatory biomarkers and objectively measured physical activity and sleep during and after chemotherapy for gynecologic cancer; thus, we conducted a longitudinal study to address this gap. Women with gynecologic cancer (patients) and non-cancer controls (controls) completed assessments before chemotherapy cycles 1, 3, and 6 (controls assessed contemporaneously), as well as at 6- and 12-month follow-ups. Physical activity and sleep were measured using wrist-worn actigraphs and sleep diaries, and blood was drawn to quantify circulating levels of inflammatory markers. Linear and quadratic random-effects mixed models and random-effects fluctuation mixed models were used to examine physical activity and sleep over time, as well as the associations with inflammatory biomarkers. On average, patients (<i>n</i> = 97) and controls (<i>n</i> = 104) were 62 and 58 years old, respectively. Compared to controls, patients were less active, more sedentary, had more time awake after sleep onset, and had lower sleep efficiency (<i>p</i>-values < 0.05). Across groups, higher levels of TNF-α were associated with more sedentary time and less efficient sleep (<i>p</i>-values ≤ 0.05). Higher levels of IL-1β, TNF-α, and IL-6 were associated with lower levels of light physical activity (<i>p</i>-values < 0.05). Associations between inflammatory biomarkers, physical activity, and sleep did not differ between patients and controls. Given these results, we speculate that inflammation may contribute to less physical activity and more sleep problems that persist even 12 months after completing chemotherapy.https://www.mdpi.com/2072-6694/15/15/3882gynecologic cancerphysical activitysleepinflammation
spellingShingle Danielle B. Tometich
Aasha I. Hoogland
Brent J. Small
Michelle C. Janelsins
Crystal Bryant
Yvelise Rodriguez
Brian D. Gonzalez
Xiaoyin Li
Hailey W. Bulls
Brian W. James
Bianca Arboleda
Claudia Colon-Echevarria
Mary K. Townsend
Shelley S. Tworoger
Paulo Rodriguez
Laura B. Oswald
Julienne E. Bower
Sachin M. Apte
Robert M. Wenham
Hye Sook Chon
Mian M. Shahzad
Heather S. L. Jim
Relationships among Inflammatory Biomarkers and Objectively Assessed Physical Activity and Sleep during and after Chemotherapy for Gynecologic Malignancies
Cancers
gynecologic cancer
physical activity
sleep
inflammation
title Relationships among Inflammatory Biomarkers and Objectively Assessed Physical Activity and Sleep during and after Chemotherapy for Gynecologic Malignancies
title_full Relationships among Inflammatory Biomarkers and Objectively Assessed Physical Activity and Sleep during and after Chemotherapy for Gynecologic Malignancies
title_fullStr Relationships among Inflammatory Biomarkers and Objectively Assessed Physical Activity and Sleep during and after Chemotherapy for Gynecologic Malignancies
title_full_unstemmed Relationships among Inflammatory Biomarkers and Objectively Assessed Physical Activity and Sleep during and after Chemotherapy for Gynecologic Malignancies
title_short Relationships among Inflammatory Biomarkers and Objectively Assessed Physical Activity and Sleep during and after Chemotherapy for Gynecologic Malignancies
title_sort relationships among inflammatory biomarkers and objectively assessed physical activity and sleep during and after chemotherapy for gynecologic malignancies
topic gynecologic cancer
physical activity
sleep
inflammation
url https://www.mdpi.com/2072-6694/15/15/3882
work_keys_str_mv AT daniellebtometich relationshipsamonginflammatorybiomarkersandobjectivelyassessedphysicalactivityandsleepduringandafterchemotherapyforgynecologicmalignancies
AT aashaihoogland relationshipsamonginflammatorybiomarkersandobjectivelyassessedphysicalactivityandsleepduringandafterchemotherapyforgynecologicmalignancies
AT brentjsmall relationshipsamonginflammatorybiomarkersandobjectivelyassessedphysicalactivityandsleepduringandafterchemotherapyforgynecologicmalignancies
AT michellecjanelsins relationshipsamonginflammatorybiomarkersandobjectivelyassessedphysicalactivityandsleepduringandafterchemotherapyforgynecologicmalignancies
AT crystalbryant relationshipsamonginflammatorybiomarkersandobjectivelyassessedphysicalactivityandsleepduringandafterchemotherapyforgynecologicmalignancies
AT yveliserodriguez relationshipsamonginflammatorybiomarkersandobjectivelyassessedphysicalactivityandsleepduringandafterchemotherapyforgynecologicmalignancies
AT briandgonzalez relationshipsamonginflammatorybiomarkersandobjectivelyassessedphysicalactivityandsleepduringandafterchemotherapyforgynecologicmalignancies
AT xiaoyinli relationshipsamonginflammatorybiomarkersandobjectivelyassessedphysicalactivityandsleepduringandafterchemotherapyforgynecologicmalignancies
AT haileywbulls relationshipsamonginflammatorybiomarkersandobjectivelyassessedphysicalactivityandsleepduringandafterchemotherapyforgynecologicmalignancies
AT brianwjames relationshipsamonginflammatorybiomarkersandobjectivelyassessedphysicalactivityandsleepduringandafterchemotherapyforgynecologicmalignancies
AT biancaarboleda relationshipsamonginflammatorybiomarkersandobjectivelyassessedphysicalactivityandsleepduringandafterchemotherapyforgynecologicmalignancies
AT claudiacolonechevarria relationshipsamonginflammatorybiomarkersandobjectivelyassessedphysicalactivityandsleepduringandafterchemotherapyforgynecologicmalignancies
AT maryktownsend relationshipsamonginflammatorybiomarkersandobjectivelyassessedphysicalactivityandsleepduringandafterchemotherapyforgynecologicmalignancies
AT shelleystworoger relationshipsamonginflammatorybiomarkersandobjectivelyassessedphysicalactivityandsleepduringandafterchemotherapyforgynecologicmalignancies
AT paulorodriguez relationshipsamonginflammatorybiomarkersandobjectivelyassessedphysicalactivityandsleepduringandafterchemotherapyforgynecologicmalignancies
AT lauraboswald relationshipsamonginflammatorybiomarkersandobjectivelyassessedphysicalactivityandsleepduringandafterchemotherapyforgynecologicmalignancies
AT julienneebower relationshipsamonginflammatorybiomarkersandobjectivelyassessedphysicalactivityandsleepduringandafterchemotherapyforgynecologicmalignancies
AT sachinmapte relationshipsamonginflammatorybiomarkersandobjectivelyassessedphysicalactivityandsleepduringandafterchemotherapyforgynecologicmalignancies
AT robertmwenham relationshipsamonginflammatorybiomarkersandobjectivelyassessedphysicalactivityandsleepduringandafterchemotherapyforgynecologicmalignancies
AT hyesookchon relationshipsamonginflammatorybiomarkersandobjectivelyassessedphysicalactivityandsleepduringandafterchemotherapyforgynecologicmalignancies
AT mianmshahzad relationshipsamonginflammatorybiomarkersandobjectivelyassessedphysicalactivityandsleepduringandafterchemotherapyforgynecologicmalignancies
AT heathersljim relationshipsamonginflammatorybiomarkersandobjectivelyassessedphysicalactivityandsleepduringandafterchemotherapyforgynecologicmalignancies